Yura Group is a specialized company in the international distribution of pharma-grade cannabis derivatives. It is part of a unique vertical integration in the cannabis industry developed by the Canadian holding company Ikänik-Pideka. This integration encompasses research activities, genetic development, cultivation, pharmaceutical extract manufacturing, raw material and finished product manufacturing for the food and cosmetic industry, logistics and fulfillment, as well as international B2B and B2C distribution. Additionally, Yura Group has a network of proprietary points of sale (dispensaries). Founded in 2020, the company offers direct access to a wide range of cannabis products, including the option for customized products, leveraging its indoor growing capacity based on 55 registered genetics in production centers located in California, U.S. and Bogotá, Colombia. The company operates in the pharmaceutical, wellness, and beauty industries, providing a unique offering in the cannabis market. With a strong focus on pharmaceutical-grade distribution and vertical integration, Yura Group presents an innovative approach to the cannabis industry.
There is no investment information
No recent news or press coverage available for Yura Group .